Kythera Biopharmaceuticals

Science & innovation in aesthetic medici

KYTHERA Biopharmaceuticals, Inc., formerly known as AESTHERx, Inc., was founded in August 2005 and is a privately held biopharmaceutical company located north of Los Angeles in southern California. KYTHERA is focused on science and innovation in...

Founded in 2005
Total money raised: $98.4M

91301 27200 West Agoura Road
Suite 200


Phone: (818) 587-4500

Keith Leonard President and CEO
Frederick Beddingfield Chief Medical Officer
John Smither CFO
Todd Gross Vice President, Clinical Affairs
Susan Lundeen Vice President, Human Resources
Nancy Jorgesen Vice President, Product, Systems and Alliance Management
Jere Fellmann Vice President, Clinical Operations
Deepak Chadha Vice President, Regulatory Affairs
David Schnell Board of Directors
Nathaniel David Board of Directors
Keith Klein General Counsel
Serge Lichtsteiner Vice President, Research
Majed Kheir Senior Director, Supply Chain and Planning
Mary O’Sullivan Senior Director, Regulatory Affairs
Richard Hake Senior Director, Intellectual Property
Dennis Fenton Board of Directors
Camille Samuels Board of Directors
Robert T. Nelsen Board Member
Elisabeth Sandoval Chief Commercial Officer
Ryan Irvine Vice President, Medical Affairs
Paul F. Lizzul Medical Director
James McElvain Senior Director, Analytical and QC
Jane Wolf Senior Director, Marketing
F. Michael Ball Board of Directors
François Kress Board of Directors
Joseph Turner Board of Directors
Nathaniel David Chief Science Officer
Frederick Beddingfield Vice President and Global Therapeutic Area Head
Serge Lichtsteiner Consultant
Serge Lichtsteiner Director of Molecular Biology, Director of Molecular and Cell Biology
Serge Lichtsteiner Independent Consultant

May, 2012

Kythera files $86M IPO to support fat-busting drug

September, 2011

Kythera Biopharmaceuticals raised $37.4M in a Series D round from Versant Ventures, ARCH Venture Partners, Prospect Venture Partners, JAFCO, Invus Financial Advisors, Bbt Capital Management, and Altitude Life Science Ventures

KYTHERA Biopharmaceuticals Closed $37.4M Series D Financing

August, 2010

Bayer, Kythera ink $373M dermatology deal

May, 2008

Kythera Biopharmaceuticals raised $30M in a Series C round from Versant Ventures, WS Investments, Prospect Venture Partners, ARCH Venture Partners, Bbt Capital Management, Apothecary Capital, Jafco Life Science, and Altitude Life Science Ventures

July, 2006

Kythera Biopharmaceuticals raised $30M in a Series B round from Prospect Venture Partners, ARCH Venture Partners, Versant Ventures, Altitude Life Science Ventures, UCLA Venture Fund, and Wilson Sonsini Goodrich & Rosati

KYTHERA Raises $30 Million In Series B Financing

September, 2005

Kythera Biopharmaceuticals raised $1M in unattributed round from Versant Ventures

August, 2005

Kythera Biopharmaceuticals was founded on August, 2005